Amgen Inc.

Amgen Inc. Stock

25.82P/E
€216.35BMarket capitalisation
US$17.25Earnings
2.10 %Dividend yield

Current price

—
1D
1W
1M
3M
6M
1Y
3Y
Max

Company description

Amgen is a leader in biotechnology-based human therapeutics. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introducedits first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drugs Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx Pharmaceuticals bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). The 2023 Horizon acquisition brought several rare-disease drugs, including thyroid eye disease drug Tepezza. Amgenalso has a growing biosimilar portfolio.

Amgen Inc. is registered in the following country: United States of America (Exchange: USNASD).

Key metrics

Key metrics and master data for the Amgen Inc. stock.

Market capitalisation
€216.35B
P/E
25.82
P/B
16.71
P/S
6.23
P/CF
20.05
Issued shares 541M Units

Return

Here you can see the performance of the Amgen Inc. stock.

PeriodPerfor­mance
1 Week-5.03 %
1 Month+6.15 %
3 Months+7.42 %
6 Months+41.87 %
1 Year+36.43 %
YTD+44.15 %

Dividends

The Amgen Inc. stock pays an annual dividend. With an (expected) annual dividend of £9.0215, the current stock price results in a dividend yield of 2.10 %.

Dividend typeAnnual dividend
(Expected) annual dividend £9.0215
Dividend yield 2.10 %

Splits

The table shows the splits of the Amgen Inc. share.

DateRatio
22.11.19991:0.5
01.03.19992:1

Which ETF contains the Amgen Inc. stock?

The Amgen Inc. stock is contained in a total of 0 ETFs with at least 1%. You can find a list of these ETFs in the following table. With —, Amgen Inc. has the largest weight in .

Name
Weighting
Region
Country
TER
Replication
Volume (£m)

Frequently asked questions

Here you can find all answers to your questions about the Amgen Inc. stock.

Master data is provided by Morningstar (stocks, ETFs, funds), CoinGecko (cryptocurrencies) and Isarvest GmbH. Price data is at least 15-minute delayed exchange prices (stocks, ETFs, funds) or NAV prices (ETFs, funds). Real-time prices – where available – are provided by the providers and Lang & Schwarz (stocks, ETFs, funds) and CoinGecko (cryptocurrencies).

Isarvest GmbH assumes no liability for the information presented and cannot guarantee that the data is complete and accurate.

Affiliate notice *
Links marked with an asterisk (*) are advertising or affiliate links. If you purchase or sign up through this link, we receive compensation from the provider. This comes at no additional cost or disadvantage to you. We use this revenue to fund our free services. Thank you for your support.